Armand Keating
Chief Tech/Sci/R&D Officer bij ROQUEFORT THERAPEUTICS PLC
Profiel
Armand Keating is the founder of panCELLa, Inc. founded in 2015.
He is currently a Director at Tissue Regeneration Therapeutics, Inc. and Pancella Therapeutics, Inc. He is also the Chief Medical Officer at Roquefort Therapeutics Plc since 2022.
Dr. Keating's former positions include being a Professor at the University of Toronto, President of the American Society of Hematology, President of the American Society for Blood & Marrow Transplantation, and Chief Medical Services at Princess Margaret Hospital.
Actieve functies van Armand Keating
Bedrijven | Functie | Begin |
---|---|---|
ROQUEFORT THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 16-09-2022 |
Tissue Regeneration Therapeutics, Inc.
Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada. | Director/Board Member | - |
Pancella Therapeutics, Inc.
Pancella Therapeutics, Inc. BiotechnologyHealth Technology Pancella Therapeutics, Inc. develops novel therapies for geno dermatoses. The company is headquartered in Toronto, Canada. | Director/Board Member | - |
panCELLa, Inc.
panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The private company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Founder | 01-01-2015 |
Eerdere bekende functies van Armand Keating
Bedrijven | Functie | Einde |
---|---|---|
Princess Margaret Hospital | Chief Tech/Sci/R&D Officer | - |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | President | - |
American Society for Blood & Marrow Transplantation | President | - |
University of Toronto | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ROQUEFORT THERAPEUTICS PLC | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Tissue Regeneration Therapeutics, Inc.
Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
American Society for Blood & Marrow Transplantation | |
Princess Margaret Hospital | |
Pancella Therapeutics, Inc.
Pancella Therapeutics, Inc. BiotechnologyHealth Technology Pancella Therapeutics, Inc. develops novel therapies for geno dermatoses. The company is headquartered in Toronto, Canada. | Health Technology |
panCELLa, Inc.
panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The private company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Commercial Services |